salvigenin has been researched along with oleanolic acid in 3 studies
Studies (salvigenin) | Trials (salvigenin) | Recent Studies (post-2010) (salvigenin) | Studies (oleanolic acid) | Trials (oleanolic acid) | Recent Studies (post-2010) (oleanolic acid) |
---|---|---|---|---|---|
27 | 0 | 19 | 4,169 | 31 | 2,404 |
Protein | Taxonomy | salvigenin (IC50) | oleanolic acid (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2.045 | |
Phospholipase A2 | Homo sapiens (human) | 3 | |
DNA polymerase beta | Homo sapiens (human) | 6.8667 | |
DNA polymerase beta | Rattus norvegicus (Norway rat) | 5.6 | |
Receptor-type tyrosine-protein phosphatase C | Homo sapiens (human) | 1 | |
Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | 3.065 | |
Tissue factor | Homo sapiens (human) | 0.005 | |
Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 4.38 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.8444 | |
Liver carboxylesterase 1 | Homo sapiens (human) | 0.1 | |
Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.065 | |
M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.98 | |
Dual specificity protein phosphatase 3 | Homo sapiens (human) | 5.4 | |
Transcription factor p65 | Homo sapiens (human) | 2.4 | |
Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.065 | |
Protease | Human immunodeficiency virus 1 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Çulhaoğlu, B; Dirmenci, T; Topçu, G; Yapar, G | 1 |
Hayes, T; Ross, SA; Srivedavyasasri, R | 1 |
De Mieri, M; Hamburger, M; Mofidi Tabatabaei, S; Moridi Farimani, M; Nejad-Ebrahimi, S; Neuburger, M; Salehi, P | 1 |
3 other study(ies) available for salvigenin and oleanolic acid
Article | Year |
---|---|
Bioactive constituents of Salvia chrysophylla Stapf.
Topics: Antioxidants; Cholinesterase Inhibitors; Diterpenes; Flavones; Lamiaceae; Lipid Peroxidation; Methylene Chloride; Oleanolic Acid; Plant Extracts; Salvia; Triterpenes; Ursolic Acid | 2013 |
Phytochemical and biological evaluation of Salvia apiana.
Topics: Abietanes; California; Drug Evaluation, Preclinical; Flavones; Magnetic Resonance Spectroscopy; Mexico; Oleanolic Acid; Phytochemicals; Plant Extracts; Plant Leaves; Plants, Medicinal; Receptor, Cannabinoid, CB1; Receptors, Opioid; Salvia; Triterpenes; Ursolic Acid | 2017 |
A nor-diterpene from Salvia sahendica leaves.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Crystallography, X-Ray; Diterpenes; Female; Flavones; Hexanes; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Oleanolic Acid; Plant Extracts; Plant Leaves; Salvia; Sitosterols; Staphylococcus aureus | 2017 |